% Expired Patents = 33.3

Forward Citations = 10

Loading Chart...

11 inventors (with patents filed for the assignee):

Ernesto Menta (5 out of 36 patents)

Silvano Spinelli (2 out of 40 patents)

Nicoletta Pescalli (2 out of 3 patents)

4. Valeria Livi (1 out of 9 patents)

5. Ambrogio Oliva (1 out of 13 patents)

6. Massimo Broggini (1 out of 1 patent)

7. Maurizio D'Incalci (1 out of 1 patent)

8. Giovanni Da Re (1 out of 1 patent)

9. Marco Conti (1 out of 3 patents)

10. Simonetta D'Alo' (1 out of 2 patents)

11. Paul Krapcho (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 7189840 - Oncosuppressive gene (2007-03-13),

2. 6987122 - 2-(1H-indol-3-yl)-2-oxo-acetic acid amides with antitumor activity (2006-01-17),

3. 6753342 - 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity (2004-06-22),

4. 6596889 - Nitrates of bis-platinum complexes with polyamine ligands (2003-07-22),

5. 6207655 - Bis-phosphonate confugates with alkylating moieties having antitumor activity (2001-03-27),

6. 6034092 - 2-[2-[(2-hydroxyethyl)amino]ethy [ (2000-03-07),

Novuspharma S.p.a. is a pharmaceutical company based in Italy. The company specializes in the research, development, and commercialization of innovative therapies for various medical conditions. With a focus on oncology and rare diseases, Novuspharma is dedicated to improving the lives of patients through cutting-edge treatments. The company is known for its commitment to quality, innovation, and patient care.

Profile summary based on public USPTO records.